JNSPG Journal Club


Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas 

  • William Couldwell

    Editor-in-Chief, Neurosurgical Focus

  • Aaron Cohen-Gadol

    Associate Editor, Neurosurgical Focus

  • Nidal Omar

  • Melissa Chambers

  • E. Antonio Chiocca

  • Gelerah Zadeh

  • , ,